Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The myeloid-binding peptide adenoviral vector enables multi-organ vascular endothelial gene targeting.

Lu ZH, Kaliberov S, Zhang J, Muz B, Azab AK, Sohn RE, Kaliberova L, Du Y, Curiel DT, Arbeit JM.

Lab Invest. 2014 Aug;94(8):881-92. doi: 10.1038/labinvest.2014.78. Epub 2014 Jun 23.

2.

A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism.

Alberti MO, Deshane JS, Chaplin DD, Pereboeva L, Curiel DT, Roth JC.

Gene Ther. 2013 Jul;20(7):733-41. doi: 10.1038/gt.2012.91. Epub 2012 Nov 22.

3.

Adenoviral targeting using genetically incorporated camelid single variable domains.

Kaliberov SA, Kaliberova LN, Buggio M, Tremblay JM, Shoemaker CB, Curiel DT.

Lab Invest. 2014 Aug;94(8):893-905. doi: 10.1038/labinvest.2014.82. Epub 2014 Jun 16.

4.

Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.

Denby L, Work LM, Graham D, Hsu C, von Seggern DJ, Nicklin SA, Baker AH.

Hum Gene Ther. 2004 Nov;15(11):1054-64.

PMID:
15610606
5.

Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation.

Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboeva L, Gerson SL, Curiel DT.

PLoS One. 2012;7(5):e37812. doi: 10.1371/journal.pone.0037812. Epub 2012 May 18.

6.

Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytia.

Chen HH, Cawood R, El-Sherbini Y, Purdie L, Bazan-Peregrino M, Seymour LW, Carlisle RC.

Mol Ther. 2011 Jan;19(1):67-75. doi: 10.1038/mt.2010.209. Epub 2010 Sep 28.

7.

Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.

Lewis TB, Glasgow JN, Glandon AM, Curiel DT, Standaert DG.

PLoS One. 2010 Sep 17;5(9). pii: e12672. doi: 10.1371/journal.pone.0012672.

9.

Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin.

Krasnykh V, Belousova N, Korokhov N, Mikheeva G, Curiel DT.

J Virol. 2001 May;75(9):4176-83.

10.

Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice.

Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Curiel DT, Arbeit JM.

PLoS One. 2013 Dec 23;8(12):e83933. doi: 10.1371/journal.pone.0083933. eCollection 2013.

11.

Targeting of high-capacity adenoviral vectors.

Biermann V, Volpers C, Hussmann S, Stock A, Kewes H, Schiedner G, Herrmann A, Kochanek S.

Hum Gene Ther. 2001 Sep 20;12(14):1757-69.

PMID:
11560769
12.

Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.

Olmsted-Davis EA, Gugala Z, Gannon FH, Yotnda P, McAlhany RE, Lindsey RW, Davis AR.

Hum Gene Ther. 2002 Jul 20;13(11):1337-47.

PMID:
12162816
13.

Development of adenovirus serotype 35 as a gene transfer vector.

Seshidhar Reddy P, Ganesh S, Limbach MP, Brann T, Pinkstaff A, Kaloss M, Kaleko M, Connelly S.

Virology. 2003 Jul 5;311(2):384-93.

14.

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.

Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E, Hackett NR, Crystal RG, Mastrangeli A.

Hum Gene Ther. 1997 Jan 1;8(1):99-109.

PMID:
8989999
15.

Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus.

Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH.

Mol Ther. 2001 Dec;4(6):534-42.

16.
17.

Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.

Koizumi N, Mizuguchi H, Sakurai F, Yamaguchi T, Watanabe Y, Hayakawa T.

J Virol. 2003 Dec;77(24):13062-72.

18.
19.

Development and assessment of human adenovirus type 11 as a gene transfer vector.

Stone D, Ni S, Li ZY, Gaggar A, DiPaolo N, Feng Q, Sandig V, Lieber A.

J Virol. 2005 Apr;79(8):5090-104.

20.

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

Stevenson SC, Rollence M, Marshall-Neff J, McClelland A.

J Virol. 1997 Jun;71(6):4782-90.

Supplemental Content

Support Center